nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC10—Etoposide—uterine cancer	0.129	0.193	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—uterine cancer	0.0878	0.132	CbGbCtD
Sildenafil—CYP1A1—Progesterone—uterine cancer	0.0686	0.103	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0549	0.0824	CbGbCtD
Sildenafil—CYP3A7—Progesterone—uterine cancer	0.0549	0.0824	CbGbCtD
Sildenafil—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0417	0.0626	CbGbCtD
Sildenafil—CYP3A5—Progesterone—uterine cancer	0.0412	0.0618	CbGbCtD
Sildenafil—CYP2C19—Progesterone—uterine cancer	0.0332	0.0499	CbGbCtD
Sildenafil—CYP2C9—Progesterone—uterine cancer	0.0276	0.0415	CbGbCtD
Sildenafil—CYP2D6—Progesterone—uterine cancer	0.0253	0.0379	CbGbCtD
Sildenafil—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0242	0.0364	CbGbCtD
Sildenafil—CYP2E1—Etoposide—uterine cancer	0.0237	0.0356	CbGbCtD
Sildenafil—CYP3A5—Etoposide—uterine cancer	0.0184	0.0277	CbGbCtD
Sildenafil—CYP3A4—Progesterone—uterine cancer	0.0161	0.0241	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—uterine cancer	0.00771	0.0116	CbGbCtD
Sildenafil—CYP3A4—Etoposide—uterine cancer	0.00719	0.0108	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—uterine cancer	0.0049	0.00736	CbGbCtD
Sildenafil—PDE5A—artery—uterine cancer	0.00385	0.086	CbGeAlD
Sildenafil—PDE6G—lymph node—uterine cancer	0.0016	0.0359	CbGeAlD
Sildenafil—PDE5A—epithelium—uterine cancer	0.00146	0.0326	CbGeAlD
Sildenafil—PDE5A—uterine cervix—uterine cancer	0.00145	0.0323	CbGeAlD
Sildenafil—ABCC10—myometrium—uterine cancer	0.00142	0.0318	CbGeAlD
Sildenafil—PDE5A—smooth muscle tissue—uterine cancer	0.00141	0.0314	CbGeAlD
Sildenafil—PDE5A—renal system—uterine cancer	0.00135	0.0303	CbGeAlD
Sildenafil—ABCC5—uterine cervix—uterine cancer	0.00132	0.0296	CbGeAlD
Sildenafil—ABCC5—decidua—uterine cancer	0.00126	0.0282	CbGeAlD
Sildenafil—ADORA2A—female reproductive system—uterine cancer	0.00119	0.0266	CbGeAlD
Sildenafil—ABCC10—uterine cervix—uterine cancer	0.0011	0.0247	CbGeAlD
Sildenafil—PDE5A—female reproductive system—uterine cancer	0.00108	0.0242	CbGeAlD
Sildenafil—ABCC10—decidua—uterine cancer	0.00105	0.0235	CbGeAlD
Sildenafil—ABCC10—renal system—uterine cancer	0.00103	0.0231	CbGeAlD
Sildenafil—ABCC10—endometrium—uterine cancer	0.000999	0.0224	CbGeAlD
Sildenafil—PDE5A—female gonad—uterine cancer	0.000986	0.022	CbGeAlD
Sildenafil—PDE5A—vagina—uterine cancer	0.00098	0.0219	CbGeAlD
Sildenafil—ABCC10—mammalian vulva—uterine cancer	0.000967	0.0216	CbGeAlD
Sildenafil—ABCC10—uterus—uterine cancer	0.000921	0.0206	CbGeAlD
Sildenafil—ABCC5—female gonad—uterine cancer	0.000901	0.0202	CbGeAlD
Sildenafil—ABCC5—vagina—uterine cancer	0.000896	0.02	CbGeAlD
Sildenafil—ABCC4—renal system—uterine cancer	0.000857	0.0192	CbGeAlD
Sildenafil—ABCC10—female reproductive system—uterine cancer	0.000828	0.0185	CbGeAlD
Sildenafil—ABCC4—uterus—uterine cancer	0.000764	0.0171	CbGeAlD
Sildenafil—ABCC10—female gonad—uterine cancer	0.000753	0.0169	CbGeAlD
Sildenafil—ABCC10—vagina—uterine cancer	0.000749	0.0167	CbGeAlD
Sildenafil—ABCC4—female reproductive system—uterine cancer	0.000687	0.0154	CbGeAlD
Sildenafil—PDE5A—lymph node—uterine cancer	0.000634	0.0142	CbGeAlD
Sildenafil—ABCC4—female gonad—uterine cancer	0.000625	0.014	CbGeAlD
Sildenafil—CYP1A1—epithelium—uterine cancer	0.000619	0.0139	CbGeAlD
Sildenafil—CYP1A1—uterine cervix—uterine cancer	0.000614	0.0137	CbGeAlD
Sildenafil—CYP3A5—uterine cervix—uterine cancer	0.000601	0.0134	CbGeAlD
Sildenafil—ABCC5—lymph node—uterine cancer	0.00058	0.013	CbGeAlD
Sildenafil—CYP1A1—renal system—uterine cancer	0.000575	0.0129	CbGeAlD
Sildenafil—CYP3A5—renal system—uterine cancer	0.000562	0.0126	CbGeAlD
Sildenafil—CYP1A1—mammalian vulva—uterine cancer	0.000537	0.012	CbGeAlD
Sildenafil—CYP2E1—renal system—uterine cancer	0.000524	0.0117	CbGeAlD
Sildenafil—CYP2C19—vagina—uterine cancer	0.000517	0.0116	CbGeAlD
Sildenafil—CYP1A1—uterus—uterine cancer	0.000512	0.0115	CbGeAlD
Sildenafil—ABCC10—lymph node—uterine cancer	0.000484	0.0108	CbGeAlD
Sildenafil—CYP1A1—female reproductive system—uterine cancer	0.00046	0.0103	CbGeAlD
Sildenafil—CYP2C9—female reproductive system—uterine cancer	0.000443	0.00991	CbGeAlD
Sildenafil—CYP3A4—renal system—uterine cancer	0.000422	0.00943	CbGeAlD
Sildenafil—CYP2E1—female reproductive system—uterine cancer	0.00042	0.00939	CbGeAlD
Sildenafil—CYP1A1—female gonad—uterine cancer	0.000419	0.00937	CbGeAlD
Sildenafil—CYP1A1—vagina—uterine cancer	0.000416	0.00931	CbGeAlD
Sildenafil—CYP2D6—renal system—uterine cancer	0.000415	0.00928	CbGeAlD
Sildenafil—CYP3A5—female gonad—uterine cancer	0.000409	0.00916	CbGeAlD
Sildenafil—CYP3A5—vagina—uterine cancer	0.000407	0.0091	CbGeAlD
Sildenafil—ABCC4—lymph node—uterine cancer	0.000402	0.00899	CbGeAlD
Sildenafil—CYP3A4—female reproductive system—uterine cancer	0.000338	0.00755	CbGeAlD
Sildenafil—CYP2D6—female reproductive system—uterine cancer	0.000332	0.00743	CbGeAlD
Sildenafil—CYP2D6—female gonad—uterine cancer	0.000302	0.00676	CbGeAlD
Sildenafil—CYP1A1—lymph node—uterine cancer	0.000269	0.00602	CbGeAlD
Sildenafil—Skin disorder—Etoposide—uterine cancer	0.000132	0.000536	CcSEcCtD
Sildenafil—Hyperhidrosis—Etoposide—uterine cancer	0.000131	0.000533	CcSEcCtD
Sildenafil—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000131	0.000532	CcSEcCtD
Sildenafil—Abdominal pain upper—Doxorubicin—uterine cancer	0.000131	0.000532	CcSEcCtD
Sildenafil—Hypokalaemia—Doxorubicin—uterine cancer	0.00013	0.00053	CcSEcCtD
Sildenafil—Angina pectoris—Epirubicin—uterine cancer	0.00013	0.00053	CcSEcCtD
Sildenafil—Breast disorder—Doxorubicin—uterine cancer	0.000129	0.000526	CcSEcCtD
Sildenafil—Anorexia—Etoposide—uterine cancer	0.000129	0.000526	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000129	0.000524	CcSEcCtD
Sildenafil—Bronchitis—Epirubicin—uterine cancer	0.000129	0.000523	CcSEcCtD
Sildenafil—Diarrhoea—Dactinomycin—uterine cancer	0.000128	0.000521	CcSEcCtD
Sildenafil—Nasopharyngitis—Doxorubicin—uterine cancer	0.000128	0.000521	CcSEcCtD
Sildenafil—Hypotension—Etoposide—uterine cancer	0.000127	0.000515	CcSEcCtD
Sildenafil—Gastritis—Doxorubicin—uterine cancer	0.000127	0.000515	CcSEcCtD
Sildenafil—Muscular weakness—Doxorubicin—uterine cancer	0.000126	0.000513	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000126	0.000513	CcSEcCtD
Sildenafil—Abdominal distension—Doxorubicin—uterine cancer	0.000125	0.000507	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000124	0.000505	CcSEcCtD
Sildenafil—Dysphagia—Doxorubicin—uterine cancer	0.000124	0.000503	CcSEcCtD
Sildenafil—Influenza—Doxorubicin—uterine cancer	0.000124	0.000503	CcSEcCtD
Sildenafil—Asthma—Doxorubicin—uterine cancer	0.000124	0.000503	CcSEcCtD
Sildenafil—Pollakiuria—Epirubicin—uterine cancer	0.000124	0.000502	CcSEcCtD
Sildenafil—Photosensitivity reaction—Epirubicin—uterine cancer	0.000122	0.000496	CcSEcCtD
Sildenafil—Paraesthesia—Etoposide—uterine cancer	0.000122	0.000495	CcSEcCtD
Sildenafil—Weight increased—Epirubicin—uterine cancer	0.000122	0.000495	CcSEcCtD
Sildenafil—Dyspnoea—Etoposide—uterine cancer	0.000121	0.000492	CcSEcCtD
Sildenafil—Hyperglycaemia—Epirubicin—uterine cancer	0.000121	0.000491	CcSEcCtD
Sildenafil—Somnolence—Etoposide—uterine cancer	0.000121	0.00049	CcSEcCtD
Sildenafil—Angina pectoris—Doxorubicin—uterine cancer	0.000121	0.00049	CcSEcCtD
Sildenafil—Pneumonia—Epirubicin—uterine cancer	0.00012	0.000488	CcSEcCtD
Sildenafil—Infestation—Epirubicin—uterine cancer	0.000119	0.000485	CcSEcCtD
Sildenafil—Infestation NOS—Epirubicin—uterine cancer	0.000119	0.000485	CcSEcCtD
Sildenafil—Vomiting—Dactinomycin—uterine cancer	0.000119	0.000485	CcSEcCtD
Sildenafil—Bronchitis—Doxorubicin—uterine cancer	0.000119	0.000484	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000118	0.000481	CcSEcCtD
Sildenafil—Rash—Dactinomycin—uterine cancer	0.000118	0.000481	CcSEcCtD
Sildenafil—Decreased appetite—Etoposide—uterine cancer	0.000118	0.00048	CcSEcCtD
Sildenafil—Renal failure—Epirubicin—uterine cancer	0.000117	0.000477	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Etoposide—uterine cancer	0.000117	0.000476	CcSEcCtD
Sildenafil—Fatigue—Etoposide—uterine cancer	0.000117	0.000476	CcSEcCtD
Sildenafil—Neuropathy peripheral—Epirubicin—uterine cancer	0.000117	0.000475	CcSEcCtD
Sildenafil—Stomatitis—Epirubicin—uterine cancer	0.000116	0.000473	CcSEcCtD
Sildenafil—Pain—Etoposide—uterine cancer	0.000116	0.000472	CcSEcCtD
Sildenafil—Constipation—Etoposide—uterine cancer	0.000116	0.000472	CcSEcCtD
Sildenafil—Urinary tract infection—Epirubicin—uterine cancer	0.000116	0.000471	CcSEcCtD
Sildenafil—Conjunctivitis—Epirubicin—uterine cancer	0.000116	0.000471	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000115	0.000468	CcSEcCtD
Sildenafil—Sweating—Epirubicin—uterine cancer	0.000114	0.000465	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—uterine cancer	0.000114	0.000465	CcSEcCtD
Sildenafil—Haematuria—Epirubicin—uterine cancer	0.000114	0.000462	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000113	0.000459	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—uterine cancer	0.000113	0.000458	CcSEcCtD
Sildenafil—Epistaxis—Epirubicin—uterine cancer	0.000113	0.000457	CcSEcCtD
Sildenafil—Sinusitis—Epirubicin—uterine cancer	0.000112	0.000455	CcSEcCtD
Sildenafil—Feeling abnormal—Etoposide—uterine cancer	0.000112	0.000455	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—uterine cancer	0.000112	0.000454	CcSEcCtD
Sildenafil—Nausea—Dactinomycin—uterine cancer	0.000111	0.000453	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—uterine cancer	0.000111	0.000451	CcSEcCtD
Sildenafil—Gastrointestinal pain—Etoposide—uterine cancer	0.000111	0.000451	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—uterine cancer	0.00011	0.000449	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—uterine cancer	0.00011	0.000449	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000109	0.000445	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—uterine cancer	0.000109	0.000441	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000108	0.00044	CcSEcCtD
Sildenafil—Urticaria—Etoposide—uterine cancer	0.000108	0.000438	CcSEcCtD
Sildenafil—Haemoglobin—Epirubicin—uterine cancer	0.000108	0.000437	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—uterine cancer	0.000108	0.000437	CcSEcCtD
Sildenafil—Rhinitis—Epirubicin—uterine cancer	0.000107	0.000436	CcSEcCtD
Sildenafil—Abdominal pain—Etoposide—uterine cancer	0.000107	0.000436	CcSEcCtD
Sildenafil—Body temperature increased—Etoposide—uterine cancer	0.000107	0.000436	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—uterine cancer	0.000107	0.000436	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—uterine cancer	0.000107	0.000436	CcSEcCtD
Sildenafil—Haemorrhage—Epirubicin—uterine cancer	0.000107	0.000435	CcSEcCtD
Sildenafil—Hypoaesthesia—Epirubicin—uterine cancer	0.000107	0.000433	CcSEcCtD
Sildenafil—Pharyngitis—Epirubicin—uterine cancer	0.000106	0.000432	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—uterine cancer	0.000106	0.00043	CcSEcCtD
Sildenafil—Urinary tract disorder—Epirubicin—uterine cancer	0.000106	0.00043	CcSEcCtD
Sildenafil—Oedema peripheral—Epirubicin—uterine cancer	0.000106	0.000429	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—uterine cancer	0.000105	0.000428	CcSEcCtD
Sildenafil—Connective tissue disorder—Epirubicin—uterine cancer	0.000105	0.000428	CcSEcCtD
Sildenafil—Urethral disorder—Epirubicin—uterine cancer	0.000105	0.000427	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—uterine cancer	0.000104	0.000423	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—uterine cancer	0.000104	0.000421	CcSEcCtD
Sildenafil—Visual impairment—Epirubicin—uterine cancer	0.000103	0.000419	CcSEcCtD
Sildenafil—Erythema multiforme—Epirubicin—uterine cancer	0.000101	0.000412	CcSEcCtD
Sildenafil—Eye disorder—Epirubicin—uterine cancer	0.0001	0.000407	CcSEcCtD
Sildenafil—Hypersensitivity—Etoposide—uterine cancer	0.0001	0.000406	CcSEcCtD
Sildenafil—Tinnitus—Epirubicin—uterine cancer	9.99e-05	0.000406	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—uterine cancer	9.96e-05	0.000405	CcSEcCtD
Sildenafil—Flushing—Epirubicin—uterine cancer	9.94e-05	0.000404	CcSEcCtD
Sildenafil—Cardiac disorder—Epirubicin—uterine cancer	9.94e-05	0.000404	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—uterine cancer	9.94e-05	0.000404	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—uterine cancer	9.91e-05	0.000403	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—uterine cancer	9.86e-05	0.000401	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—uterine cancer	9.84e-05	0.0004	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—uterine cancer	9.79e-05	0.000398	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—uterine cancer	9.76e-05	0.000397	CcSEcCtD
Sildenafil—Asthenia—Etoposide—uterine cancer	9.74e-05	0.000396	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—uterine cancer	9.74e-05	0.000396	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—uterine cancer	9.72e-05	0.000395	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—uterine cancer	9.72e-05	0.000395	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—uterine cancer	9.68e-05	0.000393	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—uterine cancer	9.65e-05	0.000392	CcSEcCtD
Sildenafil—Chills—Epirubicin—uterine cancer	9.61e-05	0.000391	CcSEcCtD
Sildenafil—Pruritus—Etoposide—uterine cancer	9.61e-05	0.00039	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—uterine cancer	9.57e-05	0.000389	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—uterine cancer	9.55e-05	0.000388	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—uterine cancer	9.47e-05	0.000385	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—uterine cancer	9.38e-05	0.000381	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—uterine cancer	9.37e-05	0.000381	CcSEcCtD
Sildenafil—Erythema—Epirubicin—uterine cancer	9.32e-05	0.000379	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—uterine cancer	9.32e-05	0.000379	CcSEcCtD
Sildenafil—Diarrhoea—Etoposide—uterine cancer	9.29e-05	0.000377	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—uterine cancer	9.26e-05	0.000376	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—uterine cancer	9.24e-05	0.000375	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—uterine cancer	9.2e-05	0.000374	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—uterine cancer	9.2e-05	0.000374	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—uterine cancer	9.19e-05	0.000373	CcSEcCtD
Sildenafil—Tension—Epirubicin—uterine cancer	9.15e-05	0.000372	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—uterine cancer	9.06e-05	0.000368	CcSEcCtD
Sildenafil—Back pain—Epirubicin—uterine cancer	9.02e-05	0.000366	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—uterine cancer	8.99e-05	0.000365	CcSEcCtD
Sildenafil—Dizziness—Etoposide—uterine cancer	8.98e-05	0.000365	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—uterine cancer	8.95e-05	0.000364	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—uterine cancer	8.93e-05	0.000363	CcSEcCtD
Sildenafil—Chills—Doxorubicin—uterine cancer	8.89e-05	0.000361	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—uterine cancer	8.85e-05	0.00036	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—uterine cancer	8.79e-05	0.000357	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—uterine cancer	8.76e-05	0.000356	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—uterine cancer	8.68e-05	0.000353	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—uterine cancer	8.65e-05	0.000352	CcSEcCtD
Sildenafil—Vomiting—Etoposide—uterine cancer	8.63e-05	0.000351	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—uterine cancer	8.63e-05	0.000351	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—uterine cancer	8.63e-05	0.000351	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—uterine cancer	8.62e-05	0.00035	CcSEcCtD
Sildenafil—Agitation—Epirubicin—uterine cancer	8.57e-05	0.000348	CcSEcCtD
Sildenafil—Rash—Etoposide—uterine cancer	8.56e-05	0.000348	CcSEcCtD
Sildenafil—Dermatitis—Etoposide—uterine cancer	8.55e-05	0.000347	CcSEcCtD
Sildenafil—Headache—Etoposide—uterine cancer	8.51e-05	0.000346	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—uterine cancer	8.5e-05	0.000345	CcSEcCtD
Sildenafil—Tension—Doxorubicin—uterine cancer	8.47e-05	0.000344	CcSEcCtD
Sildenafil—Malaise—Epirubicin—uterine cancer	8.41e-05	0.000342	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—uterine cancer	8.38e-05	0.00034	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—uterine cancer	8.38e-05	0.00034	CcSEcCtD
Sildenafil—Syncope—Epirubicin—uterine cancer	8.36e-05	0.00034	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—uterine cancer	8.35e-05	0.000339	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—uterine cancer	8.35e-05	0.000339	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—uterine cancer	8.24e-05	0.000335	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—uterine cancer	8.2e-05	0.000333	CcSEcCtD
Sildenafil—Cough—Epirubicin—uterine cancer	8.14e-05	0.000331	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—uterine cancer	8.13e-05	0.00033	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—uterine cancer	8.08e-05	0.000328	CcSEcCtD
Sildenafil—Nausea—Etoposide—uterine cancer	8.06e-05	0.000328	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—uterine cancer	8.05e-05	0.000327	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—uterine cancer	8.01e-05	0.000325	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—uterine cancer	7.97e-05	0.000324	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—uterine cancer	7.94e-05	0.000323	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—uterine cancer	7.94e-05	0.000323	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—uterine cancer	7.94e-05	0.000323	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—uterine cancer	7.93e-05	0.000322	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—uterine cancer	7.91e-05	0.000321	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.88e-05	0.00032	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—uterine cancer	7.84e-05	0.000319	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—uterine cancer	7.78e-05	0.000316	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—uterine cancer	7.76e-05	0.000315	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—uterine cancer	7.75e-05	0.000315	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—uterine cancer	7.74e-05	0.000314	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—uterine cancer	7.72e-05	0.000314	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—uterine cancer	7.62e-05	0.00031	CcSEcCtD
Sildenafil—Oedema—Epirubicin—uterine cancer	7.61e-05	0.000309	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—uterine cancer	7.58e-05	0.000308	CcSEcCtD
Sildenafil—Infection—Epirubicin—uterine cancer	7.56e-05	0.000307	CcSEcCtD
Sildenafil—Cough—Doxorubicin—uterine cancer	7.53e-05	0.000306	CcSEcCtD
Sildenafil—Shock—Epirubicin—uterine cancer	7.49e-05	0.000304	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—uterine cancer	7.48e-05	0.000304	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—uterine cancer	7.46e-05	0.000303	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—uterine cancer	7.45e-05	0.000303	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—uterine cancer	7.43e-05	0.000302	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—uterine cancer	7.39e-05	0.0003	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—uterine cancer	7.36e-05	0.000299	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—uterine cancer	7.35e-05	0.000298	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—uterine cancer	7.35e-05	0.000298	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—uterine cancer	7.35e-05	0.000298	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—uterine cancer	7.32e-05	0.000297	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	7.3e-05	0.000296	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—uterine cancer	7.26e-05	0.000295	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—uterine cancer	7.25e-05	0.000295	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—uterine cancer	7.18e-05	0.000292	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—uterine cancer	7.11e-05	0.000289	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—uterine cancer	7.04e-05	0.000286	CcSEcCtD
Sildenafil—Infection—Doxorubicin—uterine cancer	7e-05	0.000284	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.93e-05	0.000282	CcSEcCtD
Sildenafil—Shock—Doxorubicin—uterine cancer	6.93e-05	0.000281	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—uterine cancer	6.91e-05	0.000281	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—uterine cancer	6.88e-05	0.00028	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—uterine cancer	6.87e-05	0.000279	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—uterine cancer	6.84e-05	0.000278	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—uterine cancer	6.83e-05	0.000278	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—uterine cancer	6.81e-05	0.000277	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—uterine cancer	6.79e-05	0.000276	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—uterine cancer	6.77e-05	0.000275	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—uterine cancer	6.71e-05	0.000273	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—uterine cancer	6.7e-05	0.000272	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—uterine cancer	6.62e-05	0.000269	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—uterine cancer	6.58e-05	0.000267	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—uterine cancer	6.57e-05	0.000267	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—uterine cancer	6.56e-05	0.000267	CcSEcCtD
Sildenafil—Constipation—Epirubicin—uterine cancer	6.51e-05	0.000264	CcSEcCtD
Sildenafil—Pain—Epirubicin—uterine cancer	6.51e-05	0.000264	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.42e-05	0.000261	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—uterine cancer	6.37e-05	0.000259	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—uterine cancer	6.32e-05	0.000257	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—uterine cancer	6.28e-05	0.000255	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—uterine cancer	6.27e-05	0.000255	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—uterine cancer	6.26e-05	0.000254	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—uterine cancer	6.22e-05	0.000253	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—uterine cancer	6.2e-05	0.000252	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—uterine cancer	6.12e-05	0.000249	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—uterine cancer	6.08e-05	0.000247	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—uterine cancer	6.07e-05	0.000247	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—uterine cancer	6.05e-05	0.000246	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—uterine cancer	6.02e-05	0.000245	CcSEcCtD
Sildenafil—Pain—Doxorubicin—uterine cancer	6.02e-05	0.000245	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—uterine cancer	6.02e-05	0.000244	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—uterine cancer	6.02e-05	0.000244	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—uterine cancer	5.8e-05	0.000236	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—uterine cancer	5.76e-05	0.000234	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—uterine cancer	5.61e-05	0.000228	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—uterine cancer	5.59e-05	0.000227	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—uterine cancer	5.57e-05	0.000226	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—uterine cancer	5.57e-05	0.000226	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—uterine cancer	5.46e-05	0.000222	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—uterine cancer	5.38e-05	0.000219	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—uterine cancer	5.21e-05	0.000212	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—uterine cancer	5.19e-05	0.000211	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—uterine cancer	5.05e-05	0.000205	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—uterine cancer	5.03e-05	0.000204	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—uterine cancer	4.98e-05	0.000202	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—uterine cancer	4.84e-05	0.000197	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—uterine cancer	4.82e-05	0.000196	CcSEcCtD
Sildenafil—Rash—Epirubicin—uterine cancer	4.8e-05	0.000195	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—uterine cancer	4.79e-05	0.000195	CcSEcCtD
Sildenafil—Headache—Epirubicin—uterine cancer	4.77e-05	0.000194	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—uterine cancer	4.66e-05	0.000189	CcSEcCtD
Sildenafil—Nausea—Epirubicin—uterine cancer	4.52e-05	0.000184	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—uterine cancer	4.48e-05	0.000182	CcSEcCtD
Sildenafil—Rash—Doxorubicin—uterine cancer	4.44e-05	0.00018	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—uterine cancer	4.44e-05	0.00018	CcSEcCtD
Sildenafil—Headache—Doxorubicin—uterine cancer	4.41e-05	0.000179	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—uterine cancer	4.18e-05	0.00017	CcSEcCtD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	3.22e-05	0.000748	CbGpPWpGaD
Sildenafil—PDE6G—Disease—ERBB2—uterine cancer	3.2e-05	0.000743	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NDUFB11—uterine cancer	3.19e-05	0.000741	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SRD5A2—uterine cancer	3.19e-05	0.000741	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—AKT1—uterine cancer	3.17e-05	0.000735	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN2B—uterine cancer	3.16e-05	0.000733	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.11e-05	0.000722	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.1e-05	0.00072	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ESR1—uterine cancer	3.05e-05	0.000709	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CXCL8—uterine cancer	2.99e-05	0.000695	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CDKN1B—uterine cancer	2.96e-05	0.000688	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—STK11—uterine cancer	2.95e-05	0.000685	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CYP19A1—uterine cancer	2.95e-05	0.000685	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.93e-05	0.00068	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.92e-05	0.000678	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—KRAS—uterine cancer	2.92e-05	0.000677	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.89e-05	0.00067	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SMAD3—uterine cancer	2.89e-05	0.00067	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.88e-05	0.000669	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	2.85e-05	0.000661	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.84e-05	0.000659	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CTNNB1—uterine cancer	2.8e-05	0.00065	CbGpPWpGaD
Sildenafil—ABCC5—Disease—FGFR2—uterine cancer	2.75e-05	0.000639	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTEN—uterine cancer	2.73e-05	0.000633	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCL2—uterine cancer	2.69e-05	0.000624	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PIK3CA—uterine cancer	2.68e-05	0.000622	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—POLD1—uterine cancer	2.65e-05	0.000615	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MTHFR—uterine cancer	2.65e-05	0.000615	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.61e-05	0.000606	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.61e-05	0.000606	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EP300—uterine cancer	2.6e-05	0.000604	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.54e-05	0.000589	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKR1C3—uterine cancer	2.51e-05	0.000581	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKR1C1—uterine cancer	2.48e-05	0.000576	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—HRAS—uterine cancer	2.48e-05	0.000575	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKR1B1—uterine cancer	2.45e-05	0.000568	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—STAR—uterine cancer	2.45e-05	0.000568	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKR1B1—uterine cancer	2.44e-05	0.000567	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—STAR—uterine cancer	2.44e-05	0.000567	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PGR—uterine cancer	2.44e-05	0.000567	CbGpPWpGaD
Sildenafil—PDE6G—Disease—NRAS—uterine cancer	2.44e-05	0.000565	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.4e-05	0.000558	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.4e-05	0.000558	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.4e-05	0.000556	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.38e-05	0.000553	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.38e-05	0.000553	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2.36e-05	0.000548	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—YWHAE—uterine cancer	2.33e-05	0.00054	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.31e-05	0.000537	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKR1B1—uterine cancer	2.31e-05	0.000536	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—STAR—uterine cancer	2.31e-05	0.000536	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	2.28e-05	0.00053	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.28e-05	0.000529	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ERBB2—uterine cancer	2.24e-05	0.00052	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FBXW7—uterine cancer	2.23e-05	0.000518	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—MTHFR—uterine cancer	2.22e-05	0.000515	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—RRM2—uterine cancer	2.21e-05	0.000513	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—AKT1—uterine cancer	2.19e-05	0.000508	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.18e-05	0.000507	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—DCN—uterine cancer	2.15e-05	0.000498	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CXCL8—uterine cancer	2.13e-05	0.000493	CbGpPWpGaD
Sildenafil—PDE6G—Disease—KRAS—uterine cancer	2.1e-05	0.000486	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CDKN1B—uterine cancer	2.08e-05	0.000482	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP11A1—uterine cancer	2.02e-05	0.000469	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—EP300—uterine cancer	2.01e-05	0.000467	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CTNNB1—uterine cancer	1.96e-05	0.000455	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STK11—uterine cancer	1.95e-05	0.000453	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CCL2—uterine cancer	1.94e-05	0.000451	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PIK3CA—uterine cancer	1.93e-05	0.000447	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—POLD1—uterine cancer	1.92e-05	0.000446	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—POLD1—uterine cancer	1.92e-05	0.000445	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTEN—uterine cancer	1.91e-05	0.000444	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.91e-05	0.000443	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—uterine cancer	1.91e-05	0.000442	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.89e-05	0.000438	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—STAR—uterine cancer	1.89e-05	0.000438	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—NRAS—uterine cancer	1.88e-05	0.000437	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.87e-05	0.000433	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SOCS3—uterine cancer	1.83e-05	0.000424	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EP300—uterine cancer	1.82e-05	0.000423	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—POLD1—uterine cancer	1.81e-05	0.00042	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.8e-05	0.000417	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.79e-05	0.000416	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HRAS—uterine cancer	1.78e-05	0.000413	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN2B—uterine cancer	1.75e-05	0.000406	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.74e-05	0.000403	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—STAR—uterine cancer	1.74e-05	0.000403	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ERBB2—uterine cancer	1.73e-05	0.000401	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—uterine cancer	1.73e-05	0.000401	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.72e-05	0.0004	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—STAR—uterine cancer	1.72e-05	0.0004	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NRAS—uterine cancer	1.71e-05	0.000396	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.7e-05	0.000395	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1R—uterine cancer	1.7e-05	0.000394	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000393	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCL8—uterine cancer	1.69e-05	0.000393	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—KRAS—uterine cancer	1.62e-05	0.000376	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—RRM2—uterine cancer	1.6e-05	0.000372	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN1B—uterine cancer	1.6e-05	0.000371	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—RRM2—uterine cancer	1.6e-05	0.000371	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SMAD3—uterine cancer	1.6e-05	0.000371	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—uterine cancer	1.57e-05	0.000365	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.57e-05	0.000365	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.57e-05	0.000365	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—DCN—uterine cancer	1.55e-05	0.000361	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—DCN—uterine cancer	1.55e-05	0.00036	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCL8—uterine cancer	1.54e-05	0.000356	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGFR2—uterine cancer	1.52e-05	0.000354	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CTNNB1—uterine cancer	1.51e-05	0.000351	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—RRM2—uterine cancer	1.51e-05	0.00035	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.49e-05	0.000345	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—STK11—uterine cancer	1.49e-05	0.000345	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP19A1—uterine cancer	1.49e-05	0.000345	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—POLD1—uterine cancer	1.48e-05	0.000344	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTEN—uterine cancer	1.47e-05	0.000342	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KRAS—uterine cancer	1.47e-05	0.000341	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—DCN—uterine cancer	1.47e-05	0.00034	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.46e-05	0.00034	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.46e-05	0.000339	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—uterine cancer	1.44e-05	0.000334	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EP300—uterine cancer	1.41e-05	0.000326	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.39e-05	0.000322	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.38e-05	0.000321	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.00032	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.38e-05	0.00032	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—uterine cancer	1.38e-05	0.00032	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—POLD1—uterine cancer	1.36e-05	0.000316	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—POLD1—uterine cancer	1.35e-05	0.000314	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—uterine cancer	1.35e-05	0.000313	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NRAS—uterine cancer	1.31e-05	0.000305	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—uterine cancer	1.3e-05	0.000303	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000303	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ESR1—uterine cancer	1.3e-05	0.000303	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.27e-05	0.000296	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.000293	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—uterine cancer	1.25e-05	0.00029	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—RRM2—uterine cancer	1.24e-05	0.000287	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—uterine cancer	1.23e-05	0.000286	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—NRAS—uterine cancer	1.23e-05	0.000286	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—uterine cancer	1.22e-05	0.000282	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DCN—uterine cancer	1.2e-05	0.000278	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—EP300—uterine cancer	1.18e-05	0.000273	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCL2—uterine cancer	1.15e-05	0.000266	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—RRM2—uterine cancer	1.14e-05	0.000264	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—STAR—uterine cancer	1.14e-05	0.000264	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.14e-05	0.000264	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—uterine cancer	1.13e-05	0.000263	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000262	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—RRM2—uterine cancer	1.13e-05	0.000261	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MTHFR—uterine cancer	1.12e-05	0.000259	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DCN—uterine cancer	1.1e-05	0.000256	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—uterine cancer	1.1e-05	0.000256	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DCN—uterine cancer	1.09e-05	0.000254	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—STK11—uterine cancer	1.08e-05	0.00025	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.08e-05	0.00025	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.08e-05	0.00025	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—STK11—uterine cancer	1.08e-05	0.00025	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.07e-05	0.000249	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.07e-05	0.000248	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—uterine cancer	1.06e-05	0.000246	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—uterine cancer	1.04e-05	0.000241	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.04e-05	0.000241	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000239	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—STK11—uterine cancer	1.02e-05	0.000236	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.02e-05	0.000236	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKR1C3—uterine cancer	9.81e-06	0.000228	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—uterine cancer	9.74e-06	0.000226	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKR1C3—uterine cancer	9.73e-06	0.000226	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—uterine cancer	9.62e-06	0.000223	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—uterine cancer	9.57e-06	0.000222	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.54e-06	0.000221	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.09e-06	0.000211	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—uterine cancer	9.07e-06	0.000211	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—uterine cancer	9.01e-06	0.000209	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—POLD1—uterine cancer	8.91e-06	0.000207	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—uterine cancer	8.86e-06	0.000206	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—uterine cancer	8.76e-06	0.000203	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—uterine cancer	8.71e-06	0.000202	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—uterine cancer	8.49e-06	0.000197	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—uterine cancer	8.37e-06	0.000194	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1C1—uterine cancer	8.34e-06	0.000193	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—STK11—uterine cancer	8.31e-06	0.000193	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP19A1—uterine cancer	8.31e-06	0.000193	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—uterine cancer	8.16e-06	0.000189	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MTHFR—uterine cancer	8.1e-06	0.000188	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MTHFR—uterine cancer	8.08e-06	0.000188	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—uterine cancer	7.96e-06	0.000185	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.8e-06	0.000181	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EP300—uterine cancer	7.78e-06	0.000181	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—STK11—uterine cancer	7.65e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP19A1—uterine cancer	7.65e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MTHFR—uterine cancer	7.63e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP19A1—uterine cancer	7.58e-06	0.000176	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—STK11—uterine cancer	7.58e-06	0.000176	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.44e-06	0.000173	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RRM2—uterine cancer	7.43e-06	0.000172	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—uterine cancer	7.37e-06	0.000171	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRAS—uterine cancer	7.28e-06	0.000169	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DCN—uterine cancer	7.21e-06	0.000167	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.12e-06	0.000165	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—uterine cancer	7.11e-06	0.000165	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.8e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.79e-06	0.000157	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.73e-06	0.000156	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.42e-06	0.000149	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—uterine cancer	6.26e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MTHFR—uterine cancer	6.25e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—uterine cancer	6.22e-06	0.000144	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—EP300—uterine cancer	5.93e-06	0.000138	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—uterine cancer	5.76e-06	0.000134	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MTHFR—uterine cancer	5.75e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MTHFR—uterine cancer	5.7e-06	0.000132	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—uterine cancer	5.57e-06	0.000129	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.51e-06	0.000128	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—uterine cancer	5.33e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.02e-06	0.000117	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—STK11—uterine cancer	5e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP19A1—uterine cancer	5e-06	0.000116	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—uterine cancer	4.7e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—uterine cancer	4.5e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—uterine cancer	4.5e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—uterine cancer	4.39e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—EP300—uterine cancer	4.3e-06	9.97e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—EP300—uterine cancer	4.29e-06	9.95e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—uterine cancer	4.25e-06	9.86e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—EP300—uterine cancer	4.05e-06	9.4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTHFR—uterine cancer	3.76e-06	8.72e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—uterine cancer	3.58e-06	8.32e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—uterine cancer	3.48e-06	8.07e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—EP300—uterine cancer	3.31e-06	7.69e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—uterine cancer	3.2e-06	7.42e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.18e-06	7.38e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—uterine cancer	3.17e-06	7.36e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—uterine cancer	3.17e-06	7.35e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—EP300—uterine cancer	3.05e-06	7.07e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—EP300—uterine cancer	3.02e-06	7.01e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—uterine cancer	3e-06	6.95e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—uterine cancer	2.6e-06	6.02e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—uterine cancer	2.59e-06	6.01e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.45e-06	5.69e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—uterine cancer	2.45e-06	5.68e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.26e-06	5.23e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.24e-06	5.19e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—uterine cancer	2.09e-06	4.85e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—uterine cancer	2e-06	4.65e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—EP300—uterine cancer	1.99e-06	4.63e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—uterine cancer	1.84e-06	4.28e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—uterine cancer	1.83e-06	4.24e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.47e-06	3.42e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—uterine cancer	1.2e-06	2.8e-05	CbGpPWpGaD
